insulin aspart-szjj

FDA Drug Profile — MERILOG

Drug Details

Generic Name
insulin aspart-szjj
Brand Names
MERILOG
Application Number
BLA761325
Sponsor
Sanofi-Aventis Deutschland GmbH
NDC Codes
4
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INSULIN ASPART

Indications and Usage

1 INDICATIONS AND USAGE MERILOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. MERILOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).